Antioxidant gene therapy against neuronal cell death

Area of Science:

• Neuroscience
• Genetics
• Biochemistry

Background:

• Oxidative stress, involving reactive oxygen and nitrogen species (ROS/RNS), is a key factor in neuronal cell death in neurodegenerative disorders and brain injuries.
• ROS/RNS accumulation contributes to mitochondrial dysfunction, impaired energy metabolism, altered metal homeostasis, and protein aggregation, activating cell death pathways.

Purpose of the Study:

• To review the potential of genetically encoded antioxidant systems for treating neurodegenerative diseases and ischemic brain damage.
• To explore gene therapy as a novel therapeutic strategy targeting oxidative stress in neurological disorders.

Main Methods:

• Review of existing research and clinical evidence on antioxidant gene therapy.
• Discussion of virus-mediated gene delivery techniques for therapeutic applications.

Main Results:

• Genetically encoded antioxidants demonstrate efficacy in counteracting neuronal loss.
• Gene therapy presents unique advantages over conventional treatments for neurological conditions.

Conclusions:

• Targeting oxidative stress with genetically encoded antioxidants via gene therapy is a promising therapeutic avenue for neurological disorders.
• Virus-mediated gene delivery holds significant potential for developing effective antioxidant gene therapies.